Follow
Rekha Jain
Rekha Jain
Scientist
Verified email at external.merckgroup.com
Title
Cited by
Cited by
Year
Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead
S Ray, PJ Reddy, R Jain, K Gollapalli, A Moiyadi, S Srivastava
Proteomics 11 (11), 2139-2161, 2011
2472011
Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer
D Dayde, I Tanaka, R Jain, MC Tai, A Taguchi
International journal of molecular sciences 18 (3), 573, 2017
1742017
Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response
S Ray, KS Kamath, R Srivastava, D Raghu, K Gollapalli, R Jain, SV Gupta, ...
Journal of proteomics 75 (10), 3063-3080, 2012
552012
Ready to put metadata on the post-2015 development agenda? Linking data publications to responsible innovation and science diplomacy
V Özdemir, E Kolker, PJ Hotez, S Mohin, B Prainsack, B Wynne, E Vayena, ...
OMICS: A Journal of Integrative Biology 18 (1), 1-9, 2014
432014
Protein microarray applications: autoantibody detection and posttranslational modification
A Atak, S Mukherjee, R Jain, S Gupta, VA Singh, N Gahoi, M KP, ...
Proteomics 16 (19), 2557-2569, 2016
422016
Personalized medicine in the age of pharmacoproteomics: A close up on India and need for social science engagement for responsible innovation in post-proteomic biology
PJ Reddy, R Jain, YK Paik, R Downey, AS Ptolemy, V Ozdemir, ...
Current pharmacogenomics and personalized medicine 9 (1), 67, 2011
422011
A Simple Protein Extraction Method for Proteomic Analysis of Diverse Biological Specimens
SRSS Panga Jaipal Reddy, Aishwarya Anand Rao, Darpan Malhotra, Samridhi ...
Current Proteomics 10, 298-311, 2013
412013
Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12
SS Rekha Jain, Prajakta Kulkarni, Snigdha Dhali, Srikanth Rapole
J Proteomics 15 (113), 127-42, 2015
27*2015
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas
I Tanaka, D Dayde, MC Tai, H Mori, LM Solis, SC Tripathi, JF Fahrmann, ...
JNCI: Journal of the National Cancer Institute 114 (2), 290-301, 2022
202022
Transcriptional analysis of JAK/STAT signaling in glioblastoma multiforme
R Jain, A Dasgupta, A Moiyadi, S Srivastava
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2012
112012
Proteomic level changes associated with S3I201 treated U87 glioma cells
R Jain, A Atak, A Yeola, S Srivastava
Journal of proteomics 150, 341-350, 2017
72017
Targeted Proteomics Workshop and International Symposium (IIT Bombay, Mumbai, India): An Accelerator for Global Proteomics
A Atak, K Mehta, A Rao, K Gollapalli, KP Manubhai, M Gandhi, M Nayak, ...
OMICS: A Journal of Integrative Biology 20 (4), 199-201, 2016
22016
Meeting Report:“Proteomics from Discovery to Function:” 6th Annual Meeting of Proteomics Society, India and International Conference—A Milestone for the Indian Proteomics …
S Gupta, PJ Reddy, S Ray, A Atak, K Gollapalli, R Jain, VG Shah, ...
OMICS: A Journal of Integrative Biology 19 (6), 329-331, 2015
22015
Systems Biology Approach for the Identification of Diagnostic and Therapeutic Targets in Medulloblastomas
JBDSS Aditi Kapoor, Vinayak Pachapur, Rekha Jain, Prateek Singh, Durairaj Renu
Current Pharmacogenomics and Personalized Medicine 11, 137-153, 2013
1*2013
Advances in antibody-based biosensors in environmental monitoring
SKB Rekha Jain, Saba Miri, Vinayak Laxman Pachapur
Tools, Techniques and Protocols for Monitoring Environmental Contaminants, 432, 2020
2020
An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
JBDSS Rekha Jain, Vinayak, Aditi Kapoor, Meghana S. Vasavada, Prateek Singh ...
Current Pharmacogenomics and Personalized Medicine 11, 118-136, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–16